DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,903,499 | +16.7% | 43,948 | +12.9% | 0.44% | +16.4% |
Q2 2023 | $9,341,520 | +1.8% | 38,923 | +6.9% | 0.38% | -1.8% |
Q1 2023 | $9,180,053 | -11.1% | 36,423 | -6.4% | 0.38% | -11.1% |
Q4 2022 | $10,330,927 | -10.1% | 38,923 | -12.5% | 0.43% | -18.6% |
Q3 2022 | $11,492,000 | +1.9% | 44,488 | 0.0% | 0.53% | +9.7% |
Q2 2022 | $11,279,000 | -13.6% | 44,488 | 0.0% | 0.48% | -3.2% |
Q1 2022 | $13,050,000 | -10.8% | 44,488 | 0.0% | 0.50% | -8.3% |
Q4 2021 | $14,637,000 | +3.6% | 44,488 | -4.1% | 0.54% | -5.9% |
Q3 2021 | $14,122,000 | +12.3% | 46,390 | -1.0% | 0.58% | +16.5% |
Q2 2021 | $12,573,000 | +15.8% | 46,850 | -2.9% | 0.50% | +10.4% |
Q1 2021 | $10,860,000 | -7.0% | 48,250 | -8.2% | 0.45% | -14.8% |
Q4 2020 | $11,672,000 | -2.5% | 52,550 | -5.5% | 0.53% | -13.3% |
Q3 2020 | $11,973,000 | +14.8% | 55,600 | -5.8% | 0.61% | +9.5% |
Q2 2020 | $10,433,000 | +18.2% | 59,000 | -7.5% | 0.56% | +2.6% |
Q1 2020 | $8,830,000 | -10.7% | 63,800 | -0.9% | 0.54% | +14.3% |
Q4 2019 | $9,883,000 | +6.7% | 64,400 | +0.4% | 0.47% | +1.1% |
Q3 2019 | $9,265,000 | +0.2% | 64,142 | -0.8% | 0.47% | -0.8% |
Q2 2019 | $9,242,000 | -2.0% | 64,658 | -13.4% | 0.47% | -3.7% |
Q1 2019 | $9,433,000 | +22.5% | 74,658 | 0.0% | 0.49% | +12.9% |
Q4 2018 | $7,699,000 | -5.1% | 74,658 | 0.0% | 0.44% | +9.8% |
Q3 2018 | $8,113,000 | +7.3% | 74,658 | -2.6% | 0.40% | +2.1% |
Q2 2018 | $7,564,000 | -6.3% | 76,658 | -7.1% | 0.39% | -5.6% |
Q1 2018 | $8,075,000 | +5.5% | 82,474 | 0.0% | 0.41% | +12.0% |
Q4 2017 | $7,656,000 | +8.5% | 82,474 | +0.3% | 0.37% | +14.0% |
Q3 2017 | $7,055,000 | -55.1% | 82,236 | -55.8% | 0.32% | -51.5% |
Q2 2017 | $15,705,000 | -1.3% | 186,100 | 0.0% | 0.66% | -2.1% |
Q1 2017 | $15,918,000 | +9.9% | 186,100 | 0.0% | 0.68% | +5.6% |
Q4 2016 | $14,487,000 | -1.0% | 186,100 | -0.3% | 0.64% | -2.3% |
Q3 2016 | $14,639,000 | -21.9% | 186,750 | +0.6% | 0.66% | -21.9% |
Q2 2016 | $18,741,000 | +7.3% | 185,550 | +0.8% | 0.84% | +4.2% |
Q1 2016 | $17,458,000 | +2.1% | 184,050 | 0.0% | 0.81% | -0.2% |
Q4 2015 | $17,094,000 | +9.0% | 184,050 | 0.0% | 0.81% | +1.8% |
Q3 2015 | $15,683,000 | -0.4% | 184,050 | 0.0% | 0.80% | +10.4% |
Q2 2015 | $15,753,000 | +0.8% | 184,050 | 0.0% | 0.72% | +1.8% |
Q1 2015 | $15,626,000 | -0.9% | 184,050 | 0.0% | 0.71% | -0.3% |
Q4 2014 | $15,775,000 | +12.8% | 184,050 | 0.0% | 0.71% | +9.2% |
Q3 2014 | $13,984,000 | -3.5% | 184,050 | 0.0% | 0.65% | -3.3% |
Q2 2014 | $14,491,000 | +5.2% | 184,050 | +0.2% | 0.67% | +1.4% |
Q1 2014 | $13,774,000 | -2.5% | 183,650 | +0.3% | 0.66% | -3.4% |
Q4 2013 | $14,131,000 | +11.4% | 183,050 | 0.0% | 0.68% | +1.5% |
Q3 2013 | $12,689,000 | +9.7% | 183,050 | +0.2% | 0.68% | +6.1% |
Q2 2013 | $11,565,000 | – | 182,700 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |